Glucosamine-Like Supplement Suppresses Symptoms Of Multiple Sclerosis

A glucosamine-like dietary supplement suppresses the damaging autoimmune response seen in multiple sclerosis.

A study by US researchers have found that a glucosamine-like dietary supplement suppresses the damaging autoimmune response seen in multiple sclerosis.

Dr. Michael Demetriou, Ani Grigorian and others at the University of California, Irvine, found that oral N-acetylglucosamine, which is similar to but more effective than the widely available glucosamine, inhibited the growth and function of abnormal T-cells that in MS incorrectly direct the immune system to attack and break down central nervous system tissue that insulates nerves.

Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses

Earlier this year, Demetriou and colleagues discovered that environmental and inherited risk factors associated with MS converge to affect how specific sugars are added to proteins regulating the disease.

"This sugar-based supplement corrects a genetic defect that induces cells to attack the body in MS, making metabolic therapy a rational approach that differs significantly from currently available treatments," said Demetriou.

Virtually all proteins on the surface of cells, including immune cells such as T-cells, are modified by complex sugar molecules of variable sizes and composition. Recent studies have linked changes in these sugars to T-cell hyperactivity and autoimmune disease," he added.

Multiple Sclerosis – Treatment to Reduce Symptoms and Modify course of Disease
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity and relieve symptoms.

The study has been published online in The Journal of Biological Chemistry.

Source-ANI

New Compound To Squelch Inflammation In Multiple Sclerosis
British researchers are excited over the discovery of a new chemical compound that could inhibit pro-inflammatory signals in multiple sclerosis (MS).

Damage Caused by Multiple Sclerosis Slowed Down by Starving Inflammatory Immune Cells
A pair of researchers report that inhibiting the ability of immune cells to use fatty acids as fuel measurably slows disease progression in a mouse model of multiple sclerosis (MS)